AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Nov 17, 2015

34983_dirs_2015-11-17_2c086167-3a77-4203-b9a8-b86f37f86d2c.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-16	Common Shares	P	2000	$0.2	Acquired	6133776	Direct
2015-11-16	Common Shares	P	200	$0.199	Acquired	6133976	Direct
2015-11-16	Common Shares	P	1800	$0.207	Acquired	6135776	Direct
2015-11-16	Common Shares	P	2500	$0.208	Acquired	6138276	Direct
2015-11-17	Common Shares	P	5000	$0.205	Acquired	6143276	Direct
2015-11-17	Common Shares	P	2600	$0.207	Acquired	6145876	Direct
2015-11-17	Common Shares	P	2500	$0.208	Acquired	6148376	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	6131776	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect